| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
We are a human-centered robotics company. Our mission is to make technical advances towards robots and humans working together side by side, with an emphasis on human-centric design. Diligent Robotics is developing a suite of artificial intelligence that enables robots to collaborate with and adapt to humans in everyday environments.
Managed Health Services is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Fayette Companies is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Peoria, IL. To find more information about Fayette Companies, please visit www.fayettecompanies.org
Vigil Health Solutions Inc. is a Victoria, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.